Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip J Johnson

Showing results (11-20 of 226) with videos related to

Pageof 23
Sort By:
JHEP Reports : Innovation in Hepatology|September 20, 2022
The ALBI score: From liver function in patients with HCC to a general measure of liver functionHidenori Toyoda, Philip J Johnson
Diagnostic and Prognostic Research|December 4, 2025
Quantifying the versatility of routinely measured prognostic factorsHamish Innes, Philip J Johnson
Hepatology (Baltimore, Md.)|January 28, 2006
Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapyWinnie Yeo, Philip J Johnson
British Journal of Cancer|August 4, 2017
Reply to 'Comment on 'Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion' 'Iman Waked, Philip J Johnson
The Veterinary Clinics of North America. Equine Practice|July 10, 2007
Evidence-based literature pertaining to thyroid dysfunction and Cushing's syndrome in the horseNat T Messer, Philip J Johnson
Best Practice & Research. Clinical Gastroenterology|March 11, 2005
Clinical trial design in hepatocellular carcinomaPhilip J Johnson, Lucinda J Billingham
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 12, 2005
Pre-operative locoregional therapy and liver transplantation for hepatocellular carcinoma: time for a randomized controlled trialDaniel H Palmer, Philip J Johnson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Reply to X. Qi et alJosep M Llovet, Philip J Johnson
JCO Precision Oncology|July 16, 2025
Intrapatient Variation in Response to Systemic Therapy in Advanced Hepatocellular CarcinomaPhilip J Johnson, Ellen L Boswell
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2017
Reply to N. Personeni et alRichard Jackson, Efty Psarelli, Philip J Johnson
Pageof 23

Showing results (11-20 of 226) with videos related to

Sort By:
Pageof 23
JHEP Reports : Innovation in Hepatology|September 20, 2022
The ALBI score: From liver function in patients with HCC to a general measure of liver functionHidenori Toyoda, Philip J Johnson
Diagnostic and Prognostic Research|December 4, 2025
Quantifying the versatility of routinely measured prognostic factorsHamish Innes, Philip J Johnson
Hepatology (Baltimore, Md.)|January 28, 2006
Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapyWinnie Yeo, Philip J Johnson
British Journal of Cancer|August 4, 2017
Reply to 'Comment on 'Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion' 'Iman Waked, Philip J Johnson
The Veterinary Clinics of North America. Equine Practice|July 10, 2007
Evidence-based literature pertaining to thyroid dysfunction and Cushing's syndrome in the horseNat T Messer, Philip J Johnson
Best Practice & Research. Clinical Gastroenterology|March 11, 2005
Clinical trial design in hepatocellular carcinomaPhilip J Johnson, Lucinda J Billingham
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 12, 2005
Pre-operative locoregional therapy and liver transplantation for hepatocellular carcinoma: time for a randomized controlled trialDaniel H Palmer, Philip J Johnson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Reply to X. Qi et alJosep M Llovet, Philip J Johnson
JCO Precision Oncology|July 16, 2025
Intrapatient Variation in Response to Systemic Therapy in Advanced Hepatocellular CarcinomaPhilip J Johnson, Ellen L Boswell
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2017
Reply to N. Personeni et alRichard Jackson, Efty Psarelli, Philip J Johnson
Pageof 23